Axovant Gene Therapies started at outperform with $18 stock price target at SVB Leerink 8:07 am ET June 21, 2019 (MarketWatch) Share Print (END) Dow Jones Newswires
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.